ISPOR - EE391 Economic Evaluations of First-Line Non-Small Cell Lung Cancer Therapies: A Systematic Review With Focus on PD-L1 Subgroups

Full Text

EE391 Economic Evaluations of First-Line Non-Small Cell Lung Cancer Therapies: A Systematic Review With Focus on PD-L1 Subgroups

Abstract

Authors

Nadia Karim Vidhi Patel Thomas Macmillan Ihtisham Sultan Björn Stollenwerk

Back to Volume 28, Supplemental Issue 12S1

Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now